XML 23 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
Quaterly Financial Information (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information
Summarized quarterly data for fiscal 2014 and 2013 are as follows (in thousands, except per share data):
 
 
1st
Quarter
 
2nd
Quarter
 
3rd
Quarter
 
4th
Quarter
Fiscal 2014 (1)
 
 
 
 
 
 
 
 
Revenues
 
$
12,997

 
$
14,587

 
$
13,881

 
$
14,143

Gross profit
 
$
3,442

 
$
4,505

 
$
4,409

 
$
4,284

Income (loss) from operations (2)
 
$
(155
)
 
$
825

 
$
1,032

 
$
816

Net income (loss)
 
$
(148
)
 
$
823

 
$
1,028

 
$
772

Net income (loss) per common share—basic (3)
 
$
(0.01
)
 
$
0.04

 
$
0.06

 
$
0.04

Net income (loss) per common share—diluted (3)
 
$
(0.01
)
 
$
0.04

 
$
0.05

 
$
0.04

 
 
 
 
 
 
 
 
 
Fiscal 2013
 
 
 
 
 
 
 
 
Revenues
 
$
11,546

 
$
12,890

 
$
12,413

 
$
12,527

Gross profit
 
$
2,817

 
$
3,793

 
$
3,818

 
$
3,688

Income (loss) from operations
 
$
(2,409
)
 
$
(632
)
 
$
2,432

 
$
780

Net income (loss)
 
$
(2,419
)
 
$
(616
)
 
$
2,512

 
$
787

Net income (loss) per common share—basic (3)
 
$
(0.13
)
 
$
(0.03
)
 
$
0.14

 
$
0.04

Net income (loss) per common share—diluted (3)
 
$
(0.13
)
 
$
(0.03
)
 
$
0.14

 
$
0.04

(1) 
On March 13, 2014, we acquired 100% of the membership interest of Telerhythmics, LLC. The results of Telerhythmics are included in Diagnostic Services since the acquisition date (See Note 3).
(2) 
Included in the income (loss) from operations for the first, second, third, and fourth quarter of 2014, are approximately $0.4 million, $0.1 million, $0.1 million, and less than $0.1 million of charges, respectively, associated with our Diagnostic Imaging and Facilities restructuring initiatives (See Note 11).
(3) 
Earnings per share are computed independently for each of the quarters presented. Therefore, the sum of the quarterly net earnings per share will not necessarily equal the total for the year.